As India celebrated becoming the first Asian nation to reach Mars, S.M. Vaidya, head of business at conglomerate Godrej's aerospace division that made the spacecraft's engine and thruster components, sounded surprisingly downbeat.
Research
China military-linked firm eyes quick approval of drug to cure Ebola
A Chinese drugmaker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola, as China joins the race to help treat a deadly outbreak of a disease that has spread from Africa to the United States and Europe.
Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology
Vernalis plc today announces that it has licensed worldwide rights in vipadenant (V2006), a small molecule A2A receptor antagonist, to RedoxTherapies Inc (Redox). Vipadenant has the potential to disrupt an immunosuppressive mechanism of tumor protection, generating improved efficacy for immunotherapies of certain cancers when used in combination.
U.S. maker of experimental Ebola drug ZMapp seeks to boost output
California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday.
Russia to launch new heavy-lift space rocket on December 25: Interfax
Russia plans to test launch its new heavy-lift Angara space rocket on Dec. 25, Interfax news agency quoted a source in the space industry as saying on Friday.
Latest News
India's low-cost mission to Mars successfully entered the red planet's orbit on Wednesday, crowning what Prime Minister Narendra Modi said was a "near impossible" push to become the only country to complete the trip on its maiden attempt.
The U.S. drive to end its reliance on Russian rocket motors got a boost this week when Amazon.com Inc founder Jeff Bezos unveiled a new engine project, but officials and industry insiders say it will take years and hundreds of millions of dollars to develop a locally built alternative.
NASA will partner with Boeing and SpaceX to build commercially owned and operated "space taxis" to fly astronauts to the International Space Station, ending U.S. dependence on Russia for rides, officials said on Tuesday.
Vernalis plc and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has confirmed that the New Drug Application ("NDA") for Tuzistra™ XR ("CCP-01") has been accepted for full review. This triggers a milestone payment from Vernalis to Tris.
Microsoft Corp co-founder Paul Allen's charitable foundation on Thursday will announce it is donating $9 million to support U.S. efforts to fight the Ebola outbreak in West Africa, a source familiar with the matter said.
Harvard University has received the largest donation in its history, the school announced on Monday: $350 million from the Morningside Foundation to the School of Public Health.
Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
A group of companies, including several large automakers, have joined a public-private research initiative to lay the groundwork for a system that wirelessly connects vehicles and helps smooth the flow of traffic, the University on Michigan said on Friday.
Oregon researchers developing a vaccine that has shown promise in preventing HIV infection in primates said on Wednesday they have been awarded a $25 million grant from the Bill & Melinda Gates Foundation.
